by Ashley | Mar 16, 2023 | Press Release
Personalized Stem Cells, Inc. (PSC) acquires two manufacturing facilities in the San Diego Biopharma corridor. The acquisition of 8,906 square feet of class A biotech space brings online immediately operating GMP cleanroom suites (4) and supporting R&D...
by Ashley | Nov 9, 2022 | Press Release
Last week, founder and CEO of Personalized Stem Cells, Inc. (PSC) and VetStem, Inc., Dr. Bob Harman, delivered a talk at the American Academy of Orthopaedic Surgeons second annual Biologics Symposium. The symposium, which took place in Washington, DC, centered on the...
by Ashley | Apr 12, 2022 | Press Release
Personalized Stem Cells, Inc. (PSC) proudly announces the addition of Dr. Anne S. Hale. Dr. Hale will serve as the company’s Chief Development Officer to help bring new regenerative medicine products to the market. PSC founder and CEO, Dr. Bob Harman, stated, “We are...
by Ashley | Feb 1, 2022 | Press Release
Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the Brazilian Health Regulatory Agency (Anvisa) authorized a Phase 2 stem cell clinical trial for patients suffering with persistent pulmonary compromise as a result of COVID-19 (aka...
by Ashley | Dec 9, 2021 | Press Release
CEO and founder of Personalized Stem Cells, Inc (PSC), Dr. Robert Harman, recently presented clinical trial results at the annual International Federation for Adipose Therapeutics and Science (IFATS) meeting in Ft. Lauderdale, FL. PSC, an adipose derived stem cell...
by Ashley | Sep 21, 2021 | Press Release
Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the first patient has been enrolled in a Brazilian Phase 2 COVID-19 stem cell clinical trial. The trial, which is being conducted by Sorrento Therapeutics (Nasdaq: SRNE,...